Know Labs, Inc. , a leading developer of non-invasive diagnostics technology released this morning an overview of its Form 10-K annual report for its fiscal year ending September 30, 2024, and ...

This week Bobbi Conner talks with MUSC's Dr. Aundrea Loftley about using a continuous glucose monitor for diabetes management ...

Desperate for insight into her symptoms, Pinelli decided on her own to start wearing a continuous glucose monitor. The data ...

Waiting on Apple to add glucose tracking on a smartwatch to learn about your blood sugar? Don't. Try a biosensor instead.

Know Labs, Inc. (NYSE American: KNW), leading developer of non-invasive diagnostics technology, today announced that, as previously disclosed in its A ...

In recent years, technological advancements in healthcare have revolutionised the management of chronic conditions like ...

FreeStyle Libre CGMs, a breakthrough in diabetes care, actually started as a failed product — but key changes made it the ...

Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today reported financial results for the fourth quarter and fiscal ...

A novel system combining high-speed video and AI algorithms could revolutionize health screenings for high blood pressure and ...

Thailand-based Disrupt Health Impact Fund closed its first deal by investing in DiaMonTech, a Germany-based deep tech startup ...

Disrupt Technology Venture, also known as Disrupt, continues to strengthen the healthcare ecosystem with its Disrupt Health ...